medigraphic.com

2005, Number S3

<< Back Next >>

Arch Cardiol Mex 2005; 75 (S3)

Association of biventricular resynchronizer and implantable cardioverter defibrillator

Robledo NR, Ruiz SJC, Méndez EF, Trujillo CR, Blanco CM

Language: Spanish
References: 30
Page: 89-95
PDF size: 90.86 Kb.


ABSTRACT

Congestive heart failure (HF) remains a major and growing public health problem despite recent therapeutical developments. Thirty to sixty percent of patients with dilated cardiomyopathy (DCM) die suddenly from cardiac arrhythmias. Cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillator (ICD) therapy are effective treatments for HF with a wide QRS and for ventricular arrhythmias respectively. Several trials are currently being performer to evaluate the cardiac resynchronization and implantable cardioverter defibrillator therapy with good results. The objective of this paper is to report the first three patients, in Mexico, that have received this combined therapy. In one patient, a three cameral pacemaker was associated with a unicameral ICD and the other two received a device with both functions. Patients were men, aged 63, 65, and 54 years, two of them with previous myocardial infarct and functional class II to IV of the NYHA. Left ventricular ejection fraction was of 25% in two patients and of 35% in the other. All patients improved their functional class and LVFE, two patients presented discharges of the ICD.


REFERENCES

  1. MERIT-HF study group: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-07.

  2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.

  3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al: Canadian Implantable Defibrillator Study (CIDS): a randomized study of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1302.

  4. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.

  5. Kuck K, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754.

  6. Josephson ME, Callans DJ, Buxton AE: The Role of the Implantable Cardioverter Defibrillator for Prevention of Sudden Cardiac Death. Ann Intern Med 2002; 133: 901-910.

  7. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al: Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk of ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335: 1933-1940.

  8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of prevention of Sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882-1890.

  9. Cazeau S, Ritter P, Bakdach S, Lazarus A, Limousin M, Henao L, et al: Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17(Pt. II): 1974-1979.

  10. Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen A, et al: Multisite pacing as a supplemental treatment of congestive heart failure. PACE 1998; 21: 2249-55.

  11. Saxon L, Kerwin W, Cahalan M, Kalman J, Olguin J, Foster E: Acute effects of intraoperative multisite ventricular function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1998; 9: 13-21.

  12. Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, et al: Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453-1458.

  13. Kuhlkamp V. The InSync 7272 ICD World Wide Investigators: Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002; 39: 790-7.

  14. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al: Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685-2694.

  15. Gronda E, Mangiavacchi M, Andreuzzi B, Municino A, Bologna A, Gasparini M, et al: What to spect from the new technologies in heart failure treatment. Eur Heart J 2000; 2(Suppl J): J41-J46.

  16. Advisory Council to Improve Outcomes Nationwide in Heart Failure: Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999; 83(2A).

  17. Wilkerson Group Survey: Congestive heart failure worldwide markets, clinical status and product development opportunities. New Medicine, Inc. 1997; Report No. 501: 1-40.

  18. Sack S, Heinzel F, Dagres N, Wieneke H, Erbel R: Cardiac resynchronization therapy in terminal heart failure: current status and prospects. Herz 2001; 26: 84-88.

  19. Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D. Congestive Heart Failure/Myocardial Responses/Valvular Heart Disease: Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects. Circulation 1993; 88: 107-115.

  20. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadechaet M, for the Ventak CHF Investigators: Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36: 824-827.

  21. Walker S, Levy TM, Rex S, Brant S, Allen J, Ilsley CJD, et al: Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure. Am J Cardiol 2000; 86: 231-233.

  22. Zagrodzky JD, Ramaswamy K, Page RL, Joglar JA, Sheehan CJ, Smith ML, et al: Biventricular pacing decreases the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am J Cardiol 2001; 87: 1208-1210.

  23. Bradley DJ, Bradley EA, Baughman KL, Berger RD, Calkins H, Goodman SN, et al: Cardiac Resynchronization and Death From Progressive Heart Failure: A Meta-analysis of Randomized Controlled Trials. JAMA 2003; 289: 730-740.

  24. Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G, et al: Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. Am J Cardiol 1999; 83: 120D-23D.

  25. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al: Multisite stimulation in cardiomyopathies (MUSTIC) Study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880.

  26. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.

  27. Saxon L, De Marco T, Schafer J, Chatterjee K, Kummar UN, Foster E, et al: Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002; 105: 1304-1310.

  28. Walker S, Levy T, Rex S, Brant S, Paul V: Preliminary results with the simultaneous use of implantable cardioverter defibrillators and permanent biventricular pacemaker. PACE 2000; 23: 365-372.

  29. Ansalone G, Ricci R, Cacciatore G, Santini M: Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing. Ital Heart J 2001; 2(12 Suppl): 1308-1314.

  30. Bocchiardo M, Padeletti L, Gasparini M, Salerno JA, Lunati M, Vivalda L, et al: Biventricular pacing in patients candidate to ICD. Eur Heart J 2000; 2(Suppl J): J36-J40.




2020     |     www.medigraphic.com